These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11325425)
1. Preparation of gellan sulfate as an artificial ligand for removal of extra domain A containing fibronectin. Miyamoto K; Asakawa Y; Arai Y; Shimizu T; Tokita M; Komai T Int J Biol Macromol; 2001 Jun; 28(5):381-5. PubMed ID: 11325425 [TBL] [Abstract][Full Text] [Related]
2. Novel plasma-separation dilayer gellan-gellan-sulfate adsorber for direct removal of extra domain A containing fibronectin from the blood of rheumatoid arthritis patients. Miyamoto K; Sugihara K; Abe Y; Nobori T; Tokita M; Komai T Int J Biol Macromol; 2002 Jun; 30(3-4):197-204. PubMed ID: 12063122 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cryogelation by the novel synthetic peptide (Gly-Arg-Lys-Lys-Thr): recognition site of extra domain A containing fibronectin for heparin in cryogelation. Miyamoto K; Kobayashi D; Maeda R; Ito T; Komai T Int J Biol Macromol; 2003 Jan; 31(4-5):207-15. PubMed ID: 12568929 [TBL] [Abstract][Full Text] [Related]
4. Immobilized gellan sulfate surface for cell adhesion and multiplication: development of cell-hybrid biomaterials using self-produced fibronectin. Miyamoto K; Kanemoto A; Hashimoto K; Tokita M; Komai T Int J Biol Macromol; 2002 Apr; 30(2):75-80. PubMed ID: 11911896 [TBL] [Abstract][Full Text] [Related]
5. Development of the selective adsorbent for EDA containing fibronectin using heparin immobilized cellulose. Miyashita K; Sakashita E; Miyamoto K; Tokita M; Komai T Int J Biol Macromol; 1998 Apr; 22(2):91-5. PubMed ID: 9585886 [TBL] [Abstract][Full Text] [Related]
6. Specific interactions between cryogel components: role of extra domain A containing fibronectin in cryogelation. Miyamoto K; Kodera N; Umekawa H; Furuichi Y; Tokita M; Komai T Int J Biol Macromol; 2002 Jun; 30(3-4):205-12. PubMed ID: 12063123 [TBL] [Abstract][Full Text] [Related]
7. Reduction of EDA(+) fibronectin and its clinical importance on cryofiltration. Kawamura A; Yonekawa M; Takahashi M; Meguro J; Yanagida N; Kurauchi N; Ikeda A; Kukita K; Sakashita E Int J Artif Organs; 1994 Oct; 17(10):559-64. PubMed ID: 7896431 [TBL] [Abstract][Full Text] [Related]
8. Development of a novel polycationic adsorbent for cryogel removal. Miyamoto K; Uchiyama R; Tokita M; Yonekawa M; Kawamura A; Miyashita K; Sakashita E; Komai T Int J Biol Macromol; 2001 Jul; 29(1):19-24. PubMed ID: 11429185 [TBL] [Abstract][Full Text] [Related]
9. Different responses to surgical stress between extra domain A+ and plasma fibronectins. Satoi S; Hiramatsu Y; Kitade H; Kwon AH; Matsui K; Miyashita K; Sakashita E; Sekiguchi K; Takahashi H; Kamiyama Y Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):225-9. PubMed ID: 10081618 [TBL] [Abstract][Full Text] [Related]
10. Fn-EDA (Fibronectin Containing Extra Domain A) in the Plasma, but Not Endothelial Cells, Exacerbates Stroke Outcome by Promoting Thrombo-Inflammation. Dhanesha N; Chorawala MR; Jain M; Bhalla A; Thedens D; Nayak M; Doddapattar P; Chauhan AK Stroke; 2019 May; 50(5):1201-1209. PubMed ID: 30909835 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis. Lemańska-Perek A; Krzyżanowska-Gołąb D; Pupek M; Klimeczek P; Witkiewicz W; Kątnik-Prastowska I Inflammation; 2016 Jun; 39(3):1059-68. PubMed ID: 27022744 [TBL] [Abstract][Full Text] [Related]
12. Increased extra domain-A containing fibronectin and hepatic dysfunction during septic response: an in vivo and in vitro study. Satoi S; Kitade H; Hiramatsu Y; Kwon AH; Takahashi H; Sekiguchi K; Uehara M; Oda M; Yanagimoto Y; Miyashita K; Sakashita E; Kamiyama Y Shock; 2000 Jun; 13(6):492-6. PubMed ID: 10847638 [TBL] [Abstract][Full Text] [Related]